Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients with pancreatic cancer (Part A):
- You are 18 years of age or older
- You have been diagnosed with pancreatic cancer that has been treated with pre-surgery therapy (neoadjuvant treatment) and you are scheduled to have surgery to remove the tumour
- You are able to communicate in Dutch or English with the research team
- You are willing to follow the study rules and requirements
- You have agreed to take part by signing a consent form before any study procedures begin
For healthy volunteers (Part B):
- You are 18 years of age or older
- You are able to communicate in Dutch or English with the research team
- You have agreed to take part by signing a consent form before any study procedures begin
Who may not be able to join:
For patients with pancreatic cancer (Part A):
- You have a history of serious allergic reactions (such as severe anaphylaxis)
- You have previously received a drug called SGM-101
- You are currently pregnant or breastfeeding
- You have any other condition that the research doctor believes could put your health at risk or affect the study results (confirm with trial site)
For healthy volunteers (Part B):
- You have previously received a drug called SGM-101
- You are currently pregnant or breastfeeding
- You have any other condition that the research doctor believes could put your health at risk or affect the study results (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Intra-operative visualization of neoadjuvant treated pancreatic tumors using Near-infrared fluorescence imaging,
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.